Jennison Associates’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-145,795
Closed -$16.9M 655
2018
Q3
$16.9M Sell
145,795
-10,739
-7% -$1.21M 0.02% 422
2018
Q2
$19.8M Sell
156,534
-5,915
-4% -$720K 0.02% 405
2018
Q1
$17.6M Sell
162,449
-60,246
-27% -$6.67M 0.02% 407
2017
Q4
$24.4M Buy
222,695
+7,319
+3% +$731K 0.02% 369
2017
Q3
$21.3M Sell
215,376
-12,146
-5% -$1.18M 0.02% 397
2017
Q2
$23M Sell
227,522
-17,077
-7% -$1.84M 0.02% 389
2017
Q1
$28.3M Sell
244,599
-12,313
-5% -$1.43M 0.03% 372
2016
Q4
$30.8M Sell
256,912
-17,852
-6% -$1.98M 0.03% 349
2016
Q3
$30.9M Buy
274,764
+3,377
+1% +$389K 0.03% 350
2016
Q2
$33.6M Buy
271,387
+56,076
+26% +$6.77M 0.04% 346
2016
Q1
$24.2M Buy
215,311
+16,325
+8% +$1.7M 0.03% 385
2015
Q4
$21.6M Sell
198,986
-28,469
-13% -$3.26M 0.02% 416
2015
Q3
$22.7M Sell
227,455
-16,821
-7% -$1.83M 0.02% 417
2015
Q2
$27.9M Buy
244,276
+241
+0.1% +$29.2K 0.03% 421
2015
Q1
$25.5M Sell
244,035
-308,804
-56% -$32.9M 0.02% 418
2014
Q4
$66.5M Sell
552,839
-395,105
-42% -$51.9M 0.06% 281
2014
Q3
$139M Sell
947,944
-16,296
-2% -$2.52M 0.13% 143
2014
Q2
$161M Sell
964,240
-256,105
-21% -$45.6M 0.15% 143
2014
Q1
$242M Buy
1,220,345
+59,576
+5% +$11.2M 0.23% 93
2013
Q4
$222M Sell
1,160,769
-10,964
-0.9% -$2.04M 0.22% 101
2013
Q3
$198M Sell
1,171,733
-7,811
-0.7% -$1.21M 0.21% 106
2013
Q2
$179M Buy
+1,179,544
New +$167M 0.2% 112

Other funds holding CLB

Jennison Associates's CLB Position: Q4 2018 in Review

Jennison Associates sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 145,795 shares — an estimated $16.9M sold.

Jennison Associates first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $242M in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Jennison Associates reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Jennison Associates sold 145,795 Core Laboratories shares in Q4 2018, an estimated $16.9M.
  • Jennison Associates first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
  • Jennison Associates's Core Laboratories position peaked at $242M in Q1 2014.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.